1. Home
  2. ORIQ vs CRVO Comparison

ORIQ vs CRVO Comparison

Compare ORIQ & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ORIQ

Origin Investment Corp I Ordinary Shares

N/A

Current Price

$10.19

Market Cap

87.6M

Sector

N/A

ML Signal

N/A

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$6.58

Market Cap

78.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORIQ
CRVO
Founded
2024
2001
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.6M
78.5M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
ORIQ
CRVO
Price
$10.19
$6.58
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$21.50
AVG Volume (30 Days)
19.4K
60.7K
Earning Date
01-01-0001
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,159,786.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.98
$1.92
52 Week High
$10.20
$16.94

Technical Indicators

Market Signals
Indicator
ORIQ
CRVO
Relative Strength Index (RSI) N/A 33.44
Support Level N/A $6.90
Resistance Level N/A $7.41
Average True Range (ATR) 0.00 0.48
MACD 0.00 -0.10
Stochastic Oscillator 0.00 14.89

Price Performance

Historical Comparison
ORIQ
CRVO

About ORIQ Origin Investment Corp I Ordinary Shares

Origin Investment Corp I is a blank check company.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: